PULMONX CORPORATION — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 30 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$23M↓-4.9%
2025-09-30$22M↑+5.5%$-14M↑+1.3%-66.9%
2025-06-30$24M↑+14.8%$-15M↑+1.0%-62.0%
2025-03-31$23M↑+19.5%$-14M↓-5.1%-64.6%
2024-12-31$24M↑+23.3%
2024-09-30$20M↑+15.4%$-14M↑+5.1%-69.3%
2024-06-30$21M↑+20.9%$-15M↑+5.4%-75.2%
2024-03-31$19M↑+29.7%$-14M↑+13.3%-77.1%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$23M
↓-4.9% -$1M YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 29 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+3.6pts
77.6%
Operating Margin↑+2.4pts
-66.9%
Net Margin↑+4.5pts
-64.9%

Go deeper